BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Belhaven Biopharma Set to Unveil Promising Nasdepi(R) Data at DDL 2024

  December 11, 2024

   · 

  3 min read
• Press Releases

  Caliway Announces Successful Study Results from CBL-0204, a CBL-514 Phase 2b Study for Reducing Abdominal Subcutaneous Fat, Met All Primary and Secondary Efficacy Endpoints

  December 11, 2024

   · 

  6 min read
• Press Releases

  Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

  New collaboration to pioneer next generation of plant-based ingredients for healthier food and beverages

  December 11, 2024

   · 

  6 min read
• 

  Press Releases

  Okogen Inc. Secures $3.3M to Advance Phase 2b Clinical Program for Pink Eye (Acute Infectious Conjunctivitis)

  December 11, 2024

   · 

  1 min read
• Press Releases

  RapidPulse Receives FDA Approval to Begin IDE Study in Ischemic Stroke Using Innovative Cyclic Aspiration System – Recently Completed Clinical Trial Shows Significantly Higher First Pass and Frontline Success Rates

  December 11, 2024

   · 

  3 min read
• Press Releases

  GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz™

  December 11, 2024

   · 

  5 min read
• Press Releases

  CORRECTING and REPLACING Publication in NPJ Vaccines Highlights Benefits of Stratis® Intramuscular Delivery of DNA Vaccine for Hantaviruses

  December 11, 2024

   · 

  5 min read
• Press Releases

  CatalYm’s Visugromab Phase 1/2a Data Demonstrating Clinical Proof-of-Concept for Reversing Resistance to Checkpoint Inhibitors through GDF-15 Neutralization Published in Nature

  December 11, 2024

   · 

  6 min read
• Press Releases

  Susan G. Komen® Honors Five Exceptional Leaders Who Have Transformed Breast Cancer Research and Patient Care

  December 11, 2024

   · 

  7 min read
• Press Releases

  OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®

  December 11, 2024

   · 

  6 min read